🇺🇸 Retapamulin Ointment, 1% in United States

Retapamulin Ointment, 1% (Retapamulin Ointment, 1%) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Retapamulin Ointment, 1% in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Retapamulin Ointment, 1% approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Retapamulin Ointment, 1% in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.